2.81
+0.59(+26.58%)
Currency In USD
| Previous Close | 2.22 |
| Open | 2.2 |
| Day High | 3.82 |
| Day Low | 2.04 |
| 52-Week High | 6.89 |
| 52-Week Low | 0.56 |
| Volume | 66.54M |
| Average Volume | 5.72M |
| Market Cap | 46.45M |
| PE | -2.01 |
| EPS | -1.4 |
| Moving Average 50 Days | 1.16 |
| Moving Average 200 Days | 1.49 |
| Change | 0.59 |
If you invested $1000 in iBio, Inc. (IBIO) 10 years ago, it would be worth $1 as of December 10, 2025 at a share price of $2.81. Whereas If you bought $1000 worth of iBio, Inc. (IBIO) shares 5 years ago, it would be worth $4.8 as of December 10, 2025 at a share price of $2.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iBio to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 24, 2025 9:15 PM GMT
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the 8th Annual Evercore Healthcare Conference, taking place December 2–4, 20
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
GlobeNewswire Inc.
Oct 30, 2025 11:00 AM GMT
Previously reported data showed that in a diet-induced obesity mouse model, IBIO-610 drives fat-selective, GLP-1-synergistic weight loss and prevents weight regain following GLP-1 treatment discontinuation New non-human primate data projects a human
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire Inc.
Oct 23, 2025 11:00 AM GMT
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place Nov